DIPHERELINE
Powder and solvent for prolonged-release suspension for injection, 11.25mg/2ml
RxActive license
Active substance (INN)
triptorelin
Pharmaceutical form
Pharmaceutical formPowder and solvent for prolonged-release suspension for injection
Strength11.25mg/2ml
PackagingUkupno 1 bočica staklena sa praškom za suspenziju za injekciju sa produženim oslobađanjem i 1 ampula sa 2ml rastvarača u kartonskoj kutiji
ManufacturerPharmaswiss d.o.o., Serbia
Therapeutic groupAntineoplastic and immunomodulating agents (L02AE04)
Marketing authorization holderPHARMASWISS - MONTENEGRO, PHARMASWISS DOO BEOGRAD, DIO STRANOG DRUŠTVA U PODGORICI
Authorization dateSeptember 23, 2024
Analogs in Montenegro
2Other medicines with the same active substance
Source: CInMED register